Board Meeting Details
- Meeting scheduled for Monday, August 10, 2026
- Two main agenda items to be considered:
- Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026
- Consideration of fundraising through various methods including equity shares, securities convertible into equity shares, or combination thereof
Fundraising Methods Under Consideration
- Further public offer
- Rights issue
- American Depository Receipts/Global Depository Receipts
- Foreign Currency Convertible Bonds
- Qualified institutions placement
- Debt issue
- Preferential issue
- Any other method permitted by applicable laws
Approval Requirements
Fundraising subject to approval of shareholders at an Extra-Ordinary General Meeting or through Postal Ballot and required regulatory/statutory approvals.
Trading Window Status
- Trading window closure referenced from previous communication dated June 26, 2026
- Closure implemented pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct
- Affected parties: All Directors, Designated Persons, their immediate relatives, and specified Connected Persons
- Closure period: Effective from July 01, 2026
- Reopening date: Thursday, August 13, 2026